SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-23-033784
Filing Date
2023-09-26
Accepted
2023-09-26 17:41:17
Documents
1
Period of Report
2023-09-22

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 6264
  Complete submission text file 0001493152-23-033784.txt   8227
Mailing Address C/O VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY STREET CAMBRIDGE MA 02139
Business Address
Lewis-Hall Freda C (Reporting) CIK: 0001437909 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41245 | Film No.: 231281417

Mailing Address 4995 MURPHY CANYON ROAD, SUITE 300 SAN DIEGO CA 92123
Business Address 4995 MURPHY CANYON ROAD, SUITE 300 SAN DIEGO CA 92123 (760) 471 8536
CONDUIT PHARMACEUTICALS INC. (Issuer) CIK: 0001896212 (see all company filings)

IRS No.: 873272543 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 11421 GOLDEN EAGLE COURT NAPLES FL 34120
Business Address 11421 GOLDEN EAGLE COURT NAPLES FL 34120 3174967573
Intelmed LLC (Reporting) CIK: 0001994123 (see all company filings)

State of Incorp.: FL
Type: 3 | Act: 34 | File No.: 001-41245 | Film No.: 231281416